Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.

Authors

Abstract

Introduction. In Italy, regional governments are in charge of implementing cervical, breast and colorectal cancer screening programmes. The 2020 Coronavirus pandemic led to a national lockdown and the temporary suspension of several non-urgent healthcare activities, including cancer screening. This paper aims to describe the results of a national survey carried out by the National Centre for Screening Monitoring (ONS) on cervical, breast and colorectal cancer screening activities in 2020.
Materials and methods. A national survey was conducted by ONS in 2020 to assess: the number of screening invitations by Region; the volumes of screening tests and the attitude to attend the screening programme compared to 2019; the number of delayed diagnoses of malignant or pre-malignant lesions caused by the slowing down of screening programmes, based on the average Region-specific screening detection rate for cervical, breast and colorectal cancers.
Results. Screening tests for breast, colorectal and cervical cancer decreased by 37.6%, 45.5% and 43.4% in 2020 compared with 2019. In 2020 the estimated numbers of undiagnosed lesions are: 3,324 breast cancers, 1,299 colorectal cancers, 7,474 colorectal advanced adenomas and 2,782 CIN2 or more severe cervical lesions. Participation in cancer screening programmes decreased by 15%, 15% and 20%, for cervical, breast and CRC screening, respectively.
Discussion and conclusions. An urgent call to action is needed to prevent further delays
and to limit the impact of the pandemic on cancer diagnosis and prevention.

Share on

Downloads

Authors

Francesca Battisti - Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Firenze, Italy https://orcid.org/0000-0001-5778-5820

Patrizia Falini - Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Firenze, Italy

Giuseppe Gorini - Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Firenze, Italy

Priscilla Sassoli De Bianchi - Servizio prevenzione collettiva e sanità pubblica, Direzione generale cura della persona, salute e welfare, Regione Emilia-Romagna, Bologna, Italy

Paola Armaroli - SSD Epidemiologia e Screening, Centro di prevenzione oncologica, Azienda ospedaliero-universitaria città della salute e della scienza di Torino, Italy

Pamela Giubilato - SSD Epidemiologia e Screening, Centro di prevenzione oncologica, Azienda ospedaliero-universitaria città della salute e della scienza di Torino, Italy

Paolo Giorgi Rossi - Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Italy

Manuel Zorzi - Registro tumori del Veneto, Azienda Zero, Padova, Italy

Jessica Battagello - Registro tumori del Veneto, Azienda Zero, Padova, Italy

Carlo Senore - SSD Epidemiologia e Screening, Centro di prevenzione oncologica, Azienda ospedaliero-universitaria città della salute e della scienza di Torino, Italy

Marco Zappa - Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Firenze, Italy

Paola Mantellini - Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Firenze

How to Cite
Battisti, F. ., Falini, P. ., Gorini, G., Sassoli De Bianchi, P. ., Armaroli, P., Giubilato, P., … Mantellini, P. (2022). Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses. Annali dell’Istituto Superiore Di Sanità, 58(1), 16–24. Retrieved from https://annali.iss.it/index.php/anna/article/view/1420
  • Abstract viewed - 470 times